What is the latest AMBUJACEM stock price?
The latest stored price for AMBUJACEM is Rs 414.50 as of 2026-08-21.
gimli
AMBUJACEM stock AI analysis
AMBUJACEM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
AMBUJA CEMENTS LTD is a mid-cap stock in Construction Materials. This Gimli page shows the latest available AMBUJACEM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹414.50
1W return
-0.72%
1M return
-5.98%
3M return
-5.03%
6M return
-19.04%
1Y return
-29.60%
Market cap
₹102,995.67 cr
PE
25.76
PB
1.43
ROE
+5.89%
ROCE
+2.80%
RSI
41.64
Turnover
₹229.09 cr
Why it can matter in screens
- Momentum: AMBUJACEM is below 50DMA, below 200DMA; RSI is 41.64.
- Returns: 1D +0.85%, 1W -0.72%, 1M -5.98%, 3M -5.03%, 1Y -29.60%.
- Trend levels: 52W high ₹452.00, 52W low ₹404.80, off high -8.30%.
- Liquidity: latest turnover is ₹229.09 cr; volume vs 20D is +1.75%.
- Valuation/profitability: PE 25.76, PB 1.43, ROE +5.89%, ROCE +2.80%.
- Growth: 3Y sales CAGR +24.04%, 3Y profit CAGR +22.79%.
Quick Answers
Is AMBUJACEM above its 50DMA and 200DMA?
AMBUJACEM is below 50DMA, below 200DMA. The latest 50DMA is 428.14 and the latest 200DMA is 479.07.
What are AMBUJACEM PE, ROE and ROCE?
AMBUJACEM has PE 25.76, ROE +5.89%, and ROCE +2.80% in Gimli's latest available snapshot.
How has AMBUJACEM performed recently?
AMBUJACEM has returned -5.98% over 1 month, -5.03% over 3 months, and -29.60% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 9,474.00 cr | 1,739.00 cr | 577.00 cr | 2.32 |
| 2026-03-31 | 10,891.68 cr | 1,601.66 cr | 1,830.15 cr | 7.41 |
| 2025-12-31 | 10,180.52 cr | 1,430.29 cr | 203.70 cr | 0.82 |
| 2025-09-30 | 5,256.61 cr | 2,018.00 cr | 1,387.55 cr | nan |
| 2025-06-30 | 10,244.11 cr | 2,261.34 cr | 787.88 cr | 3.20 |
| 2025-03-31 | 9,894.41 cr | 2,580.20 cr | 1,025.49 cr | 4.16 |
| 2024-12-31 | 8,498.10 cr | 3,067.04 cr | 2,158.21 cr | 8.86 |
| 2024-09-30 | 7,516.11 cr | 1,331.48 cr | 455.96 cr | 1.85 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 39,969.40 cr | 7,092.79 cr | 4,728.18 cr | 19.15 |
| 2025-03-31 | 33,654.07 cr | 8,616.65 cr | 4,303.10 cr | 17.55 |
| 2024-03-31 | 32,529.79 cr | 7,800.38 cr | 3,573.40 cr | 17.98 |
| 2023-03-31 | 20,937.70 cr | 4,015.44 cr | 2,553.49 cr | 12.49 |
| 2022-12-31 | 30,982.83 cr | 4,188.41 cr | 1,938.46 cr | 9.76 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 89,606.60 cr | 891.59 cr | 865.93 cr | 71,846.24 cr |
| 2025-03-31 | 81,106.36 cr | 5,043.32 cr | 788.50 cr | 63,947.09 cr |
| 2024-03-31 | 65,103.68 cr | 3,007.10 cr | 699.01 cr | 50,842.52 cr |
| 2021-12-31 | 45,204.59 cr | 11,358.49 cr | 476.57 cr | 32,498.77 cr |
| 2020-12-31 | 39,720.70 cr | 8,571.56 cr | 470.60 cr | 29,098.49 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 5,361.53 cr | -982.80 cr | n/a |
| 2025-03-31 | 2,237.35 cr | -6,449.70 cr | n/a |
| 2024-03-31 | 5,645.82 cr | 1,163.36 cr | n/a |
| 2022-12-31 | -836.20 cr | -5,390.24 cr | n/a |
| 2021-12-31 | 5,309.16 cr | 2,975.06 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +67.33% | +5.63% | +19.65% | +9.12% | +7.39% | +0.00% |
| 2026-04-10 | +67.33% | +5.83% | +19.84% | +8.73% | +7.00% | +0.00% |
| 2026-03-31 | +67.68% | +5.87% | +20.07% | +8.92% | +6.37% | +0.00% |
| 2025-12-31 | +67.68% | +5.80% | +19.85% | +8.15% | +6.67% | +0.00% |
| 2025-09-30 | +67.68% | +5.91% | +19.63% | +8.03% | +6.78% | +0.00% |
| 2025-06-30 | +67.57% | +7.44% | +18.70% | +7.91% | +6.29% | +0.00% |
| 2025-03-31 | +67.57% | +8.60% | +17.30% | +7.81% | +6.52% | +0.00% |
| 2024-12-31 | +67.57% | +9.14% | +16.62% | +7.71% | +6.67% | +0.00% |
| 2024-09-30 | +67.57% | +10.61% | +15.19% | +6.35% | +6.63% | +0.00% |
| 2024-06-30 | +70.33% | +9.59% | +13.26% | +5.53% | +6.82% | +0.00% |
| 2024-04-17 | +70.33% | +9.90% | +12.94% | +5.37% | +6.84% | +0.00% |
| 2024-03-31 | +66.74% | +11.09% | +14.48% | +6.08% | +7.68% | +0.00% |
| 2024-03-28 | +66.74% | +11.11% | +14.43% | +6.06% | +7.72% | +0.00% |
| 2023-12-31 | +63.19% | +11.88% | +15.82% | +6.64% | +9.10% | n/a |
| 2023-09-30 | +63.19% | +11.65% | +15.53% | +6.46% | +9.63% | +100.00% |
| 2023-06-30 | +63.20% | +12.45% | +14.41% | +5.58% | +9.93% | +100.00% |
| 2023-03-31 | +63.22% | +11.16% | +14.75% | +5.80% | +10.86% | +100.00% |
| 2022-12-31 | +63.22% | +10.66% | +16.98% | +7.79% | +9.13% | +100.00% |
| 2022-09-30 | +63.22% | +11.05% | +16.53% | +7.37% | +9.21% | +100.00% |
| 2022-06-30 | +63.20% | +0.26% | +27.80% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| ULTRACEMCO | ULTRATECH CEMENT LIMITED | 340,354.23 cr | 39.828754 | +11.05% | -10.10% |
| GRASIM | GRASIM INDUSTRIES LTD | 224,320.31 cr | 37.949574 | +3.61% | +14.81% |
| SHREECEM | SHREE CEMENT LIMITED | 87,603.94 cr | 53.698627 | +7.27% | -20.67% |
| JKCEMENT | JK CEMENT LIMITED | 40,565.86 cr | 42.960474 | +14.37% | -26.41% |
| DALBHARAT | DALMIA BHARAT LIMITED | 35,262.41 cr | 49.595511 | +3.99% | -19.96% |
| ACC | ACC LIMITED | 24,551.31 cr | 12.864462 | +9.76% | -29.33% |
| RAMCOCEM | THE RAMCO CEMENTS LIMITED | 21,243.87 cr | 32.990447 | +8.29% | -19.11% |
| JSWCEMENT | JSW CEMENT LIMITED | 16,905.18 cr | -22.065099 | -17.22% | -18.15% |
Try these prompts
- Analyze AMBUJA CEMENTS with valuation, momentum and industry peers
- Compare AMBUJACEM with other Construction Materials stocks
- Show mid-cap stocks in Construction Materials above 50DMA with positive 1M return
- Find Construction Materials stocks with improving momentum and reasonable valuation
Related screen ideas
- View Construction Materials stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare AMBUJACEM with other Construction Materials stocks
Data snapshot: 2026-08-21. Not investment advice.